1 year return (CAGR)
-77.34%
Filana Therapeutics, Inc. Exchange (NASDAQ, USD)
FLNA
0.77
-0.10 (-11.18%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-65.11%
5 year return (CAGR)
-55.43%
10 year return (CAGR)
-26.28%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
37.33M
Price/Sales
-
Ent value
-5.05M
Price/Book
0.59
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.85 |
| Daily high | 0.90 |
| Daily low | 0.74 |
| Daily Volume | 2.28M |
| All-time high | 161.00 |
| 1y analyst estimate | 6.50 |
| Beta | -0.69 |
| EPS (TTM) | -0.88 |
| Dividend per share | 0.00 |
| Ex-div date | 13 Dec 2012 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| FLNA | S&P500 | |
| Current price drop from All-time high | -99.52% | -1.38% |
| Highest price drop | -99.58% | -56.47% |
| Date of highest drop | 16 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -79.47% | -10.68% |
| Avg time to new high | 1647 days | 12 days |
| Max time to new high | 6550 days | 1805 days |
News
